Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

AMRXAMRX
18 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in AMNEAL PHARMACEUTICALS INC

Connor, Clark & Lunn Investment Management Ltd. previously held 0 shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$634,000

Total Shares Change

-182,291

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$12.88
0
2025-Q3
Increased
623,258
+3.5%
$6.2M0.0%$9.87
28
2025-Q2
Increased
602,468
+14.2%
$4.9M0.0%$8.13
31
2025-Q1
Decreased
527,685
-5.0%
$4.4M0.0%$8.28
0
2024-Q4
Increased
555,655
+1.2%
$4.4M0.0%$7.83
27
2024-Q3
Decreased
548,975
-1.6%
$4.6M0.0%$8.19
0
2024-Q2
Increased
558,113
+4.6%
$3.5M0.0%$6.35
28
2024-Q1
Increased
533,434
+11.8%
$3.2M0.0%$6.06
30
2023-Q4
Decreased
476,906
-3.1%
$2.9M0.0%$6.07
0
2023-Q3
Increased
492,304
+27.8%
$2.1M0.0%$4.22
32
2023-Q2
Increased
385,214
+16.6%
$1.2M0.0%$2.87
29
2023-Q1
Increased
330,497
+41.2%
$459,3910.0%$1.36
32
2022-Q4
Increased
234,117
+52.3%
$465,8930.0%$1.99
34
2022-Q3
New
153,690
-
$310,0000.0%$2.09
32
2020-Q4
Exited
0
-100.0%
$00.0%$4.60
0
2020-Q3
Decreased
18,014
-94.0%
$70,0000.0%$3.85
0
2020-Q2
Increased
299,067
+64.1%
$1.4M0.0%$4.67
37
2020-Q1
New
182,291
-
$634,0000.0%$3.07
34

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used